Evolution of vaccination rates after the implementation of a free systematic pneumococcal vaccination in Catalonian older adults: 4-years follow-up
<p>Abstract</p> <p>Background</p> <p>The systematic vaccination with 23-valent polysaccharide pneumococcal vaccine (PPV) was introduced as a strategic objective of health for all the people over 65 in Catalonia in 1999. We analysed the evolution of the pneumococcal vacc...
Main Authors: | Ansa Xabier, Sarrá Nuria, Ester Francisco, Ochoa-Gondar Olga, Vila-Córcoles Angel, Saún Neus |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2006-09-01
|
Series: | BMC Public Health |
Online Access: | http://www.biomedcentral.com/1471-2458/6/231 |
Similar Items
-
Prevalence of high, medium and low-risk medical conditions for pneumococcal vaccination in Catalonian middle-aged and older adults: a population-based study
by: O. Ochoa-Gondar, et al.
Published: (2017-06-01) -
Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older
by: Salsench Elisabet, et al.
Published: (2010-03-01) -
Clinical effectiveness of pneumococcal vaccination against acute myocardial infarction and stroke in people over 60 years: the CAPAMIS study, one-year follow-up
by: Vila-Corcoles Angel, et al.
Published: (2012-03-01) -
Rationale and design of the <it>CAPAMIS </it>study: Effectiveness of pneumococcal vaccination against community-acquired pneumonia, acute myocardial infarction and stroke
by: Salsench Elisabet, et al.
Published: (2010-01-01) -
Evaluating clinical effectiveness of 13-valent pneumococcal conjugate vaccination against pneumonia among middle-aged and older adults in Catalonia: results from the EPIVAC cohort study
by: Angel Vila-Corcoles, et al.
Published: (2018-04-01)